Invesco Ltd. - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 56 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$141,370
-25.0%
75,599
+0.7%
0.00%
Q2 2023$188,420
+729.2%
75,068
+478.2%
0.00%
Q1 2023$22,722
-18.8%
12,984
+15.2%
0.00%
Q1 2022$28,0000.0%11,273
+5.5%
0.00%
Q4 2021$28,000
-70.8%
10,689
-44.2%
0.00%
Q3 2021$96,000
-20.0%
19,167
+18.8%
0.00%
Q2 2021$120,00016,1390.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 300,000$300,0000.08%
Polar Capital Holdings Plc 5,599,407$5,599,0000.03%
VANCE WEALTH, INC. 13,299$13,0000.01%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$39,0000.01%
BENDER ROBERT & ASSOCIATES 14,059$14,0000.01%
HoyleCohen, LLC 30,432$30,0000.00%
Inscription Capital, LLC 17,000$17,0000.00%
Ergoteles LLC 100,722$101,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 89,100$89,0000.00%
ADIRONDACK TRUST CO 2,500$3,0000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders